<n-docbody><doc bill="Y"><content.metadata.block><cmd.identifiers><cmd.cites><cmd.second.line.cite><bop/><bos/>Multidistrict Lit Man § 5:26<eos/><eop/></cmd.second.line.cite></cmd.cites></cmd.identifiers></content.metadata.block><prop.block><prop.head toc-guid=""><bop/><bos/><headtext>Multidistrict Litigation Manual</headtext><eos/><eop/></prop.head><content.metadata.block><cmd.dates><cmd.currency.default iso.d="20190501"><bop/><bos/>May 2019 Update<eos/><eop/></cmd.currency.default></cmd.dates></content.metadata.block><author.line><bop/><bos/><author>David F. Herr[<footnote.reference refid="If416cc716b3e11e99b03e53d6dd36aa2">a0</footnote.reference>]</author><eos/><eop/></author.line><prop.head toc-guid="I97b7f560933b11da99e2b07024dacc26"><bop/><bos/><label.name>Part</label.name><label.designator>I.</label.designator><headtext>Handling Cases Before the Judicial Panel on Multidistrict Litigation</headtext><eos/><eop/></prop.head><prop.head toc-guid="Id8e3eb20933b11da99e2b07024dacc26"><bop/><bos/><label.name>Chapter</label.name><label.designator>5.</label.designator><headtext>Factors in Deciding Whether Transfer Is Appropriate</headtext><eos/><eop/></prop.head></prop.block><message.block><include.copyright n-include_collection="w_wlnv_msg" n-include_guid="I1DA35ED81DD211B281BAD200220BDFCA">Copyright (c) 2017 Thomson/RIA All rights reserved.</include.copyright></message.block><section><section.front><doc.title toc-guid="I94f12b78e1e311da9c26e67ca3b71335"><head parent="doc.title"><bop/><bos/><label.name>§ </label.name><label.designator>5:26.</label.designator><headtext>Specific factors articulated by the Panel—Danger of duplicative discovery</headtext><eos/><eop/></head></doc.title></section.front><section.body><para><bop/><bos/><paratext>The Panel has stated that the prevention of duplicative discovery is one of the purposes of permitting transfer under <cite.query w-src-number="0304914028" w-seq-number="00001" w-ref-type="LQ" w-normalized-cite="28USCAS1407" w-pub-number="1000546" ID="I7a2b67406b3e11e99f73e2698c313519">28 U.S.C.A. § 1407</cite.query>[<footnote.reference refid="If4178fc06b3e11e99b03e53d6dd36aa2">1</footnote.reference>] and has also specifically identified it as a factor favoring transfer in particular cases.[<eos/><bos/><footnote.reference refid="If417b6d26b3e11e99b03e53d6dd36aa2">2</footnote.reference>] The Panel also recognizes that centralization is not the only way to deal with the risks and costs of duplicative discovery. <eos/><bos/>It has pointed out that depositions can be noticed in all related cases, that discovery can be used in other actions, that judges can direct the parties to coordinate pretrial activities, and that courts can stay actions voluntarily to allow discovery to proceed in a single action.[<eos/><bos/><footnote.reference refid="If417b6d36b3e11e99b03e53d6dd36aa2">3</footnote.reference>] The Panel has also cited the complexity of the anticipated, not just the danger of duplication, as a factor driving a decision to centralize litigation.[<eos/><bos/><footnote.reference refid="If417dde06b3e11e99b03e53d6dd36aa2">4</footnote.reference>] Conversely, the likelihood that discovery will not be required or will be minimal may militate against transfer.[<eos/><bos/><footnote.reference refid="If417dde16b3e11e99b03e53d6dd36aa2">5</footnote.reference>]</paratext><eos/><eop/></para></section.body></section><author.footnotes><footnote ID="If416cc716b3e11e99b03e53d6dd36aa2"><label.designator>a0</label.designator><footnote.body><para><bop/><bos/><paratext>Maslon Edelman Borman &amp; Brand, LLP, Minneapolis, Minnesota.<eos/></paratext><eop/></para></footnote.body></footnote></author.footnotes><footnote.block><footnote ID="If4178fc06b3e11e99b03e53d6dd36aa2"><label.designator>1</label.designator><footnote.body><para><bop/><bos/><paratext>This purpose of transfer is discussed in <cite.query w-ref-type="NA" w-normalized-cite="MDLITMANs5:26" w-pub-number="185218" ID="If4178fc16b3e11e99b03e53d6dd36aa2">§ 5:26</cite.query>. <eos/><bos/>The legislative history of <cite.query w-src-number="0304914028" w-seq-number="00002" w-ref-type="LQ" w-normalized-cite="28USCAS1407" w-pub-number="1000546" ID="I7a2bb5606b3e11e99f73e2698c313519">28 U.S.C.A. § 1407</cite.query> discussed in <cite.query w-ref-type="NA" w-normalized-cite="MDLITMANs2:3" w-pub-number="185218" ID="If417b6d06b3e11e99b03e53d6dd36aa2">§ 2:3</cite.query> also reflects this purpose. <eos/><bos/><ital>See</ital> <cite.query w-ref-type="NA" w-normalized-cite="MDLITMANs3:3" w-pub-number="185218" ID="If417b6d16b3e11e99b03e53d6dd36aa2">§ 3:3</cite.query>.<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If417b6d26b3e11e99b03e53d6dd36aa2"><label.designator>2</label.designator><footnote.body><para><bop/><bos/><paratext><ital>See, e.g.,</ital> <cite.query w-src-number="0304914028" w-serial-number="2041791929" w-seq-number="00003" w-ref-type="RP" w-pub-number="0007903" ID="I7a2c9fc16b3e11e99f73e2698c313519">In re Uber Technologies, Inc., Wage and Hour Employment Practices Litigation (No. II), 254 F. Supp. 3d 1376 (U.S.J.P.M.L. 2017)</cite.query>; <cite.query w-src-number="0304914028" w-serial-number="2040526744" w-seq-number="00004" w-ref-type="RP" w-pub-number="0007903" ID="I7a2c9fc36b3e11e99f73e2698c313519">In re Xytex Corporation Sperm Donor Products Liability Litigation, 223 F. Supp. 3d 1351 (U.S.J.P.M.L. 2016)</cite.query>; <cite.query w-src-number="0304914028" w-serial-number="2037790697" w-seq-number="00005" w-ref-type="RP" w-pub-number="0007903" ID="I7a2c9fc56b3e11e99f73e2698c313519">In re Treasury Securities Auction Antitrust Litigation, 148 F. Supp. 3d 1360 (U.S.J.P.M.L. 2015)</cite.query>; <cite.query w-src-number="0304914028" w-serial-number="2034977731" w-seq-number="00006" w-ref-type="RP" w-pub-number="0007903" ID="I7a2c9fc76b3e11e99f73e2698c313519">In re: Home Depot, Inc. Customer Data Security Breach Litigation., 65 F. Supp. 3d 1398 (U.S.J.P.M.L. 2014)</cite.query>; <cite.query w-src-number="0304914028" w-serial-number="2034595843" w-seq-number="00007" w-ref-type="RP" w-pub-number="0007903" ID="I7a2c9fc96b3e11e99f73e2698c313519">In re: London Silver Fixing, Ltd., Antitrust Litigation, 52 F. Supp. 3d 1381 (U.S.J.P.M.L. 2014)</cite.query>; <cite.query w-src-number="0304914028" w-serial-number="2005418847" w-seq-number="00008" w-ref-type="RP" w-pub-number="0004637" ID="I7a2c9fcb6b3e11e99f73e2698c313519">In re Foundry Resins Antitrust Litigation, 342 F. Supp. 2d 1346 (J.P.M.L. 2004)</cite.query>; <cite.query w-src-number="0304914028" w-serial-number="2004462986" w-seq-number="00009" w-ref-type="RP" w-pub-number="0004637" ID="I7a2c9fcd6b3e11e99f73e2698c313519">In re Starmed Health Personnel, Inc., Fair Labor Standards Act Litigation, 317 F. Supp. 2d 1380 (J.P.M.L. 2004)</cite.query> (transfer for this reason of a single action to join one other); <cite.query w-src-number="0304914028" w-serial-number="1986162810" w-seq-number="00010" w-ref-type="RP" w-pub-number="0000345" w-pinpoint-page="189" ID="I7a2c9fcf6b3e11e99f73e2698c313519">In re Dow Chemical Co. Sarabond Products Liability Litigation, 650 F. Supp. 187, 189 (J.P.M.L. 1986)</cite.query>; <cite.query w-src-number="0304914028" w-serial-number="1985161658" w-seq-number="00011" w-ref-type="RP" w-pub-number="0000345" w-pinpoint-page="635" ID="I7a2c9fd16b3e11e99f73e2698c313519">In re Air Crash at Dallas/Fort Worth Airport on Aug. 2, 1985, 623 F. Supp. 634, 635 (J.P.M.L. 1985)</cite.query>; <cite.query w-src-number="0304914028" w-serial-number="1981102724" w-seq-number="00012" w-ref-type="RP" w-pub-number="0000345" w-pinpoint-page="650" ID="I7a2c9fd36b3e11e99f73e2698c313519">In re 1980 Decennial Census Adjustment Litigation, 506 F. Supp. 648, 650 (J.P.M.L. 1981)</cite.query>; <cite.query w-src-number="0304914028" w-serial-number="1977106312" w-seq-number="00013" w-ref-type="RP" w-pub-number="0000345" w-pinpoint-page="1034" ID="I7a2c9fd56b3e11e99f73e2698c313519">In re General Tire &amp; Rubber Co. Securities Litigation, 429 F. Supp. 1032, 1034 (J.P.M.L. 1977)</cite.query>; <cite.query w-src-number="0304914028" w-serial-number="1973106208" w-seq-number="00014" w-ref-type="RP" w-pub-number="0000345" w-pinpoint-page="571" ID="I7a2c9fd76b3e11e99f73e2698c313519">In re Seeburg-Commonwealth United Merger Litigation, 362 F. Supp. 568, 571 (J.P.M.L. 1973)</cite.query>, <case.history>judgment aff&apos;d</case.history>, <cite.query w-src-number="0304914028" w-serial-number="1975111384" w-seq-number="00015" w-ref-type="RP" w-pub-number="0000350" ID="I7a2c9fd96b3e11e99f73e2698c313519">518 F.2d 402 (2d Cir. 1975)</cite.query>.<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If417b6d36b3e11e99b03e53d6dd36aa2"><label.designator>3</label.designator><footnote.body><para><bop/><bos/><paratext><cite.query w-src-number="0304914028" w-serial-number="2039935932" w-seq-number="00016" w-ref-type="RP" w-pub-number="0007903" ID="I7a2e26616b3e11e99f73e2698c313519">In re Colgate Optic White Toothpaste Marketing and Sales Practices Litigation, 232 F. Supp. 3d 1346 (U.S.J.P.M.L. 2016)</cite.query>; <cite.query w-src-number="0304914028" w-serial-number="2039510474" w-seq-number="00017" w-ref-type="RP" w-pub-number="0007903" ID="I7a2e26636b3e11e99f73e2698c313519">In re United Healthcare Services, Inc. Harvoni (Ledipasvir and Sofosbuvir) Health Insurance Litigation, 222 F. Supp. 3d 1339 (U.S.J.P.M.L. 2016)</cite.query> (cross-noticing of depositions, stipulations to use of depositions can prevent duplication); <cite.query w-src-number="0304914028" w-serial-number="2035757520" w-seq-number="00018" w-ref-type="RP" w-pub-number="0007903" ID="I7a2e26656b3e11e99f73e2698c313519">In re LVNV Funding, LLC, Fair Debt Collection Practices Act (FDCPA) Litigation, 96 F. Supp. 3d 1374 (J.P.M.L. 2015)</cite.query> (Iimited overlap); <cite.query w-src-number="0304914028" w-serial-number="2038226923" w-seq-number="00019" w-ref-type="RP" w-pub-number="0007903" ID="I7a2e26676b3e11e99f73e2698c313519">In re Credit Union Checking Account Overdraft Litigation, 158 F. Supp. 3d 1363 (J.P.M.L. 2016)</cite.query>; <cite.query w-src-number="0304914028" w-serial-number="2029837293" w-seq-number="00020" w-ref-type="RP" w-pub-number="0004637" ID="I7a2e26696b3e11e99f73e2698c313519">In re Trans Union LLC Fair Credit Reporting Act (FCRA) Litigation, 923 F. Supp. 2d 1374 (U.S.J.P.M.L. 2013)</cite.query>; <cite.query w-src-number="0304914028" w-serial-number="2027912031" w-seq-number="00021" w-ref-type="RP" w-pub-number="0004637" ID="I7a2e266b6b3e11e99f73e2698c313519">In re Crest Sensitivity Treatment &amp; Protection Toothpaste Marketing and Sales Practices Litigation, 867 F. Supp. 2d 1348 (J.P.M.L. 2012)</cite.query>.<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If417dde06b3e11e99b03e53d6dd36aa2"><label.designator>4</label.designator><footnote.body><para><bop/><bos/><paratext><ital>See</ital> <cite.query w-src-number="0304914028" w-serial-number="2030316643" w-seq-number="00022" w-ref-type="RP" w-pub-number="0004637" ID="I7a2f10c16b3e11e99f73e2698c313519">In re: Google Inc. Gmail Litigation, 936 F. Supp. 2d 1381 (U.S.J.P.M.L. 2013)</cite.query>. <eos/><bos/><ital>See also</ital> <cite.query w-src-number="0304914028" w-serial-number="2032413341" w-seq-number="00023" w-ref-type="RP" w-pub-number="0004637" ID="I7a2f10c36b3e11e99f73e2698c313519">In re: Nutramax Cosamin Marketing and Sales Practices Litigation, 988 F. Supp. 2d 1371 (U.S.J.P.M.L. 2013)</cite.query> (extensive anticipated discovery).<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If417dde16b3e11e99b03e53d6dd36aa2"><label.designator>5</label.designator><footnote.body><para><bop/><bos/><paratext><ital>See</ital> <cite.query w-src-number="0304914028" w-serial-number="2042297824" w-seq-number="00024" w-ref-type="PM" w-pub-number="0007903" ID="I7a2f85f26b3e11e99f73e2698c313519">In re American Civil Liberties Union Freedom of Information Act (FOIA) Requests Regarding Executive Order 13769, 261 F. Supp. 3d 1348 (U.S.J.P.M.L. 2017)</cite.query>.<eos/></paratext><eop/></para></footnote.body></footnote></footnote.block><content.metadata.block><cmd.royalty><cmd.copyright><bop/><bos/>Westlaw. © 2019 Thomson Reuters.  <eos/><bos/>No Claim to Orig. U.S. Govt. <eos/><bos/>Works.<eos/><eop/></cmd.copyright></cmd.royalty><cmd.identifiers><cmd.cites><cmd.first.line.cite><bop/><bos/>MDLITMAN § 5:26<eos/><eop/></cmd.first.line.cite></cmd.cites></cmd.identifiers></content.metadata.block></doc></n-docbody>
